ClinicalTrials.Veeva

Menu

Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease (FAST)

G

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Status

Not yet enrolling

Conditions

Crohn Disease

Treatments

Other: Questionnaire completion

Study type

Observational

Funder types

Other

Identifiers

NCT06250361
GETAID-2023-01

Details and patient eligibility

About

The goal of this observational study is to determine the factors associated with a delayed diagnosis and/or an immediately complicated disease for CD patients.

A questionnaire will be completed by the patients, each questionnaire has a patient section and a physician section.

Full description

Number of patients expected : at least 600, coming from all types of practices (ANGH (expert hospitals), GETAID (expert university hospitals) and CREGG (expert private practice)).

Recruitment period : 1 year

Primary endpoint : The primary endpoint is the description of the factors linked to:

  • The IBD
  • The patient (see patient questionnaire in annex 1)
  • The health care system
  • The patient's self-care

Secondary endpoint :

  • Validation of the "red flags" in a prospective cohort.
  • Comparison with the EPIMAD population, especially the location and severity.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Crohn's disease diagnosed less than a year prior to inclusion
  • Written consent
  • Age ≥ 18 years

Exclusion criteria

  • Diagnosis of Crohn's disease more than one year before inclusion
  • Patient protected by the law
  • Patient without health cover

Trial contacts and locations

0

Loading...

Central trial contact

Charlotte Mailhat, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems